Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	158.85B
Revenue (ttm)	18.77B
Net Income (ttm)	1.15B
Shares Out	316.47M
EPS (ttm)	3.63
PE Ratio	138.45
Forward PE	104.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,639
Average Volume	119,387
Open	499.45
Previous Close	501.95
Day's Range	497.00 - 504.60
52-Week Range	327.00 - 568.00
Beta	n/a
RSI	48.66
Earnings Date	Jan 29, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 4,214
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In 2024, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.